Morre-Tec Industries Acquires Vitacyclix

US manufacturer and distributor Morre-Tec Industries has acquired Vitacyclix, a producer of vitamins, nutrients and bioflavonoids for enhancing food and drink products, for an undisclosed sum. President and CEO of Morre-Tec, Leonard Glass, said New York-based Vitacyclix developed and launched the original vitamin A and D concentrates more than 55 years ago under its flagship brand, Freeman Dairy Vitamins A&D.

The acquisition adds a range of products including water-soluble vitamins, liquid concentrates and powders to Morre-Tec’s portfolio. Morre-Tec will also collaborate with the founders of Vitacyclix to market new water-soluble nutritional ingredients. These include fat-soluble vitamins, bioflavonoids, carotenoids and omega 3s created using Vitacyclix’ SOL-U-BLE technology. The technology is said to improve water solubility and absorption levels.

Michael Glass, Morre-Tec’s director of sales and marketing, said experts believe that more than 1 billion individuals are deficient in vitamin D. This deficiency has been associated with enabling a vast number of serious conditions including cancer, osteoporosis, Crohn’s disease, diabetes, multiple sclerosis, heart ailments, arthritis and autoimmune illnesses.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
19.03.2025 • News

Arkema Launches Acrylic Acid Purification Project

Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.